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T cells play a cardinal role in imparting protection against Mycobacterium tuberculosis
(Mtb). However, ample time is required before T-cells are able to evoke efficient effector
responses in the lung, where the mycobacterium inflicts disease. This delay in T cells
priming, which is termed as lag phase, provides sufficient time for Mtb to replicate and
establish itself within the host. In contrast, innate immunity efficiently curb the growth of
Mtb during initial phase of infection through several mechanisms. Pathogen recognition
by innate cells rapidly triggers a cascade of events, such as apoptosis, autophagy,
inflammasome formation and nitric oxide production to kill intracellular pathogens.
Furthermore, bactericidal mechanisms such as autophagy and apoptosis, augment the
antigen processing and presentation, thereby contributing substantially to the induction
of adaptive immunity. This manuscript highlights the role of innate immune mechanisms
in restricting the survival of Mtb during lag phase. Finally, this article provides new insight
for designing immuno-therapies by targeting innate immune mechanisms to achieve
optimum immune response to cure TB.
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INTRODUCTION
Tuberculosis continues to affect public health worldwide. About one third of the global population
is infected with Mtb but only 3–10% succumb to disease (Barry et al., 2009; Ottenhoff and
Kaufmann, 2012). Therefore, greater than 90% of infected population remains asymptomatic,
which determines the intricate balance between host immunity and Mtb. Understanding the
immune response of these asymptomatic individuals can be highly informative and will provide
potentially new pathways for the development of anti-TB drugs and vaccines.
Over the past several decades, research related to defense against Mtb was largely focused
on the T cells because of their remarkable ability to generate Mtb specific immunity, followed
by an enduring memory response to counter subsequent infections (Stenger and Modlin, 1999).
Undoubtedly, T cells play a crucial role in protection against Mtb. However, recent information
has chiseled the long belief that T cells are the sentinels in Mtb protection, in part due to
the substantial lag period between infection and the establishment of specific T-cell responses
Abbreviations: BCG, Bacillus Calmette–Guerin; DCs, dendritic cells; Mtb, Mycobacterium tuberculosis; PCD, programmed
cell death. TB, tuberculosis.
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FIGURE 1 | Innate immunity restricts the bacterial burden during lag phase of T cell response. Initiation of T cell response occurs after 9–11 days of Mtb
infection and peaks at 20–25 days (−). Delay in the duration for the generation of effective T cell response is considered as its “lag phase”. Susceptible strain (−) of
rabbit shows high bacterial burden during lag phase of T cell response; whereas resistant strain (−) signifies lesser bacterial burden. However, after initiation of T cell
response, both the strains restrict Mtb growth. It indicates that lesser bacterial burden during lag phase of T cell response in resistant strain of rabbit is due to
involvement of innate immunity.
(Shaler et al., 2012). Recruitment of DCs to the site of infection,
followed by their Mtb acquisition and transportation toward
draining lymph nodes to prime naïve T cells takes 9–11 days
after the invasion of the pathogen. Hence, T cell activation
occurs after considerable time of infection. This delay between
the onset of infection and generation of specific effector T
cells provides enough time for Mtb to establish an infection
(Figure 1). Once established, Mtb ultimately hampers the antigen
processing and priming of naïve T cells (Roberts and Robinson,
2014). Eventually, obstructs the generation and propagation of
anti-Mtb T cell responses. However, despite the lag phase in
T-cell responses,>90% of infected individuals are asymptomatic,
raising the possibility of the involvement of other factors in
controlling TB.
Lurie’s fundamental studies with resistant and susceptible
inbred rabbits proved that the innate response effectively controls
the growth of Mtb at early times of infection. After 7 days
of inhalation of tubercle bacilli, lungs of susceptible animals
showed 20–30-fold more bacteria than resistant strain (Lurie,
1964; Arthur et al., 1994) (van Crevel et al., 2002) (Figure 1).
Protection during the initial phase of infection clearly indicates
that T cells are not at the forefront in controlling the infection,
but, rather that components of the innate immune system play
a pivotal role in generating efficient immunity against Mtb.
Therefore, it is important to dissect the mechanisms responsible
for curbing the growth of Mtb during the lag phase of T cell
response. Understanding these mechanisms could pave ways in
designing novel therapeutic strategies and vaccines to enhance
the immune response more efficiently against Mtb.
Why Focus More on Innate Immunity?
In the past, the role of innate immunity was ignored in inducing
a protective response against Mtb. Recent reports show that
the function of innate immunity is even more effective than
T cell response against Mtb (Fremond et al., 2004; Nicolle et al.,
2004). Mice with defective MyD88 signaling show optimal T
cell response, yet there is no significant reduction in the lung
bacterial burden of Mtb challenged mice, compared to wild type
(Nicolle et al., 2004). In another study it was shown that MyD88
knockout mice show interferon-(IFN)-γ production in response
to mycobacterial antigens but Mtb infection became lethal within
4 weeks of post infection with 2 log10 higher CFUs in the lung
(Fremond et al., 2004). TLR-2 deficient or TLR-9 KO mice show
high levels of IFN-γ and tumor necrosis factor (TNF)-α, with
high infiltration of CD4 T cells and CD8 T cells in lungs but
these mice succumb to Mtb infection (Carlos et al., 2009). These
reports indicate that innate immunity has a more profound role
than to simply assist adaptive immunity. Moreover, an optimal
acquired immune response is not sufficient to compensate for
defective innate immunity. Collectively, these studies suggest that
it is important to dissect out the functions assisted by innate
immunity to induce a protective response against Mtb.
Innate Mechanisms Act and Foster T
Cells to React against Mtb
Based on the recent studies, innate immunity has gained
much more impetus due to its profound role in early control
of Mtb infection and in sustaining the T cell response
(Sia et al., 2015). These innate mechanisms represent the
target to explore in designing new strategies to control Mtb.
Taking into consideration all these facts, herein we compile
the contribution of the bactericidal mechanisms: autophagy,
apoptosis, inflammasome formation, and nitric oxide (NO)
production in limiting the growth of Mtb (Table 1). Additionally,
we will discuss how innate signaling delivered through pattern
recognition receptors (PRRs) such as toll like receptors (TLRs),
nucleotide binding oligomerization domain like receptors
(NLRs) can augment these mechanisms.
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TABLE 1 | The role of innate immune mechanisms in restricting the survival of Mtb during lag phase.
Mechanism Function Reference
Autophagy Provide the alternative route for antigen processing and
presentation.
Target cytosolic antigen to lysosome for degradation.
Overcome the evasion strategy of Mtb to inhibit
phagolysosome biogenesis.
Jagannath et al., 2009; Cooney et al., 2010
Apoptosis Facilitates the presentation of antigen to CD8 T cells.
Restrict the bacterial burden.
Winau et al., 2006; Andersson et al., 2014
Inflammasome Involved in maturation of IL-1β and IL-18. Fremond et al., 2007
Nitric oxide (NO) Intracellular killing of pathogen.
Regulate IL-1β secretion to control inflammation.
Flesch and Kaufmann, 1991; Chan et al., 1992; Nicholson et al., 1996; Akaki
et al., 1997; MacMicking et al., 1997; Rich et al., 1997; Kuo et al., 2000;
Nathan and Shiloh, 2000; Chan et al., 2001; Ciccone et al., 2003; Sharma
et al., 2004; Lamichhane, 2011
Autophagy
Autophagy is evolved as a stress response that endows
cells with a capability to adjust their biomass and turn
over constituents at the time of starvation. It targets the
cytoplasmic material, including macromolecules, organelles,
and cells undergoing unscheduled apoptosis to lysosomes
for degradation, thus periodically cleaning their interiors.
Furthermore, autophagy has crucial roles in various biological
processes, which include aging, development, degenerative
diseases, and cancer (Huang and Brumell, 2014; Jiang and
Mizushima, 2014). In addition, it also helps in elimination
of pathogens, which exploit the cytosolic compartment for
their regular life cycle, or those that are evolved with the
capability to arrest phago-lysosome biogenesis (Flannagan
et al., 2009). Autophagy is initiated with the sequestering of
pathogens intracellularly to form a double membrane envelope
that is known as autophagosome. Autophagosome fuses with
lysosomes to form autolysosome to degrade pathogens. Thereby,
autophagy facilitates the trafficking of mycobacteria to the
lysosome for degradation (Gutierrez et al., 2004; Deretic et al.,
2009). Similar results are reported in the case of BCG.
In addition, autophagy also transports a large proportion
of ubiquitinated proteins to lysosomes and augments the
bactericidal capacity of lysosomal fraction (Alonso et al., 2007).
Mtb escapes the immune mechanism by neutralizing the
acidification of phagosomes (Deretic et al., 2006; Russell, 2011).
Autophagy overcomes this Mtb evasion strategy by targeting
phagosomes containing bacterium to lysosomes (Jo, 2013).
Thus, autophagy provides an additional barrier to neutralize an
attempt made by the mycobacterium to manipulate phagosomes
maturation.
Noteworthy, autophagy processes bacteria for degradation
within early hours of infection, as evidenced by conversion of
autophagy marker LC3-I to LC3-II in Mtb infected DCs and Mϕs
(Khan et al., 2016). This experiment categorically indicates that
autophagy guards the host against Mtb during the initial phase of
infection. Importantly, animals with defective autophagy showed
increase in the bacterial burden in lungs of Mtb challenged
animals despite of predominance of Th17 immunity (Castillo
et al., 2012). Furthermore, these animals showed remarkable
gross tubercle lesions, in contrast to the smaller infected foci in
the lungs of control animals. It signifies that autophagy also aid
in preventing excessive inflammatory reactions in the host.
Currently, the only available vaccine for TB is BCG.
Nonetheless, BCG has failed to reduce the global TB burden.
Interestingly, one of the factors associated with the failure
of BCG in TB-endemic areas is BCG ability to hamper the
fusion of phagosome with lysosomes (Soualhine et al., 2007;
Sun et al., 2007; Gowthaman et al., 2012). This interference
in the antigen processing and presentation to T cells, results
in defective T cell response. Since autophagy can overcome
the problem of phago-lysosome biogenesis, targeting autophagy
can substantially contribute to improve efficacy of BCG vaccine
(Jagannath et al., 2009). It has been shown in a very elegant
study that mice immunized with rapamycin-treated DCs infected
with BCG showed enhanced Th1 cells mediated protection when
challenged with virulent Mtb. Rapamycin induced enhancement
in antigen presentation was attenuated when autophagy was
suppressed by 3-methyladenine or by small interfering RNA
against beclin-1 (Jagannath et al., 2009). Targeting autophagy
may open new avenues in boostering the efficacy of BCG or
immune response against Mtb. Dissecting the host factors that
regulates autophagy can help in restricting the growth of Mtb
and simultaneously improving the processing and presentation
of antigen and enhancing T cell immunity.
Autophagy can be induced due to starvation, treatment with
IFN-γ or rapamycin (Bento et al., 2015). Additionally, triggering
through PRRs has direct correlation with the induction of
autophagy. Signaling through TLR-4, TLR-3, TLR-7 and NOD-
2 receptor can potently induce autophagy (Delgado et al., 2008;
Delgado and Deretic, 2009; Cooney et al., 2010; Yuk et al., 2012).
TLR-7 triggering enables Mϕs to reduce the survival of Mtb via
induction of autophagy (Delgado et al., 2008). It was further
supported through suppression of autophagy by knocking down
beclin and Atg5 through siRNA. Innate triggering through NOD-
1 and NOD-2 enhances autophagy induction and reduces the
bacterial burden within 6 h of infection (Travassos et al., 2010).
Murine immunity related to guanosine tri-phosphate induces
autophagy and generate large autolysosomal organelles, as a
mechanism for the elimination of intracellular Mtb. Furthermore,
human Irgm1 ortholog (IRGM) augments autophagy and reduces
intracellular bacillary load (Singh et al., 2006). Many evidences
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have been documented to show the potential for autophagy based
therapies to target Mtb (Bento et al., 2015). Similarly, exploring
innate receptors to augment autophagy could also be one of the
strategies to boost the host immunity against Mtb. Moreover,
it would be beneficial in overcoming the failure associated with
BCG vaccine.
Reactive Nitrogen and Oxygen
Intermediates
Nitric oxide and reactive nitrogen intermediates (RNI) are
considered potent antimicrobial agents acquired by innate cells.
Mϕs are the major producer of NO. It is released by inducible
nitric oxide synthase (iNOs), a heme-protein that catalyzes the
oxidation of L-arginine to NO and citrulline. NO production
is a critical defense mechanism in determining the outcome
of TB infection, since it reduces the survival of Mtb (Rich
et al., 1997). This information was corroborated with the result
observed in mouse model where abrogation of iNOs activity
produces dramatic increase in microbial burden (MacMicking
et al., 1997). Further, disruption of iNOs gene expression
results in a high rate of Mtb dissemination and mortality.
Stimulation of innate molecules, such as TLRs or NODs trigger
the expression of iNOs, which ultimately kills Mtb, as evidenced
by colony forming units (CFU) assay (Chan et al., 2001). In
the mouse model of TB, NO secretion is well known to be an
antimicrobial defense mechanism. However, its role in humans
is still controversial. Forthcoming evidences indicate that human
Mϕs and alveolar epithelial cells upon infection with Mtb secrete
NO to inhibit the intracellular growth of Mtb. Additionally, iNOs
and markers associated with NO are highly expressed in the
Mϕs obtained from broncho-alveolar lavage of TB patients and
not healthy individuals (Nicholson et al., 1996). Interestingly,
patients infected with multidrug resistant (MDR) strain of Mtb
produce less NO (Sharma et al., 2004). More startling observation
came from the report that chemotherapy appears to cure TB in
immune-competent mice but fails to do so in NOS2-deficient
animals (Nathan and Shiloh, 2000). It concludes that bactericidal
drug uses NO pathway for efficient killing of Mtb (Ciccone et al.,
2003).
IFN-γ induces the production of NO (Flesch and Kaufmann,
1991). After several days of Mtb infection, T cells produce IFN-
γ. However, production and action of NO is observed within
3 h and it persists for few days in the circulation (Akaki et al.,
1997; Rich et al., 1997). Early production of NO signifies that
IFN-γ, which is a potential stimulator for NO release, is not
being released by T cells, but instead by the cells of innate
immunity such as natural killer (NK) cells and γδ T cells (Sada-
Ovalle et al., 2008). It suggests that innate immune cells are
responsible for early release of NO to restrict the growth of Mtb
during the initial period of infection. NO is also reported to
regulate the synthesis and release of several pro-inflammatory
cytokines including IL-1β, TNF-α, and IL-8, which subsequently
affect the production of NO in the feedback loop (Kuo et al.,
2000). Microbicidal activity of Mϕs is also associated with
reactive oxygen intermediates (ROI). However, their role in
constraining the growth of Mtb is not highly significant (Chan
et al., 1992; Akaki et al., 1997; Lamichhane, 2011). Probable
reason documented is that although ROI appear immediately
upon Mtb infection but Mϕs cease to produce it within 2 h of
infection. Further, ROI also have shorter half-lives.
In essence, the NO kills Mtb and as well as augments host
immunity against the pathogen is well documented in the
literature (Chan et al., 2001). It is important to mention that
TLRs signaling contributes substantially in release of NO (West
et al., 2011). 1, 25-dihydroxyvitamin D is a potent inducer of
NO and suppresses the growth of Mtb (Rockett et al., 1998).
TLRs triggering enhances the bactericidal activity of Mϕs by
upregulating the expression of the vitamin D receptor and
by inducing the enzyme that catalyzes the conversion of 25-
dihydroxyvitamin D3 to active 1, 25-dihydroxyvitamin D leading
to the induction of antimicrobial peptide cathelicidin (Liu et al.,
2006). Hence, it may be considered as a critical molecule in
designing new therapeutic strategies to treat TB. TLR ligands
are known to induce NO production in antigen presenting cells
(APCs) and NO restricts the growth of Mtb (Khan et al., 2015).
Apoptosis
Apoptosis is commonly known as ‘programmed cell death
(PCD)’. It is a phenomenon that occurs when a cell committing
suicide confines its cytoplasmic content within membrane bound
vesicles named as apoptotic bodies. These membrane bound
vesicles express molecules known as ‘eat me or find me’ signals.
‘Eat me’ signals help in the recognition of these unwanted
moieties by phagocytic cells (Behar et al., 2011). Furthermore,
phagocytic cells remove them through a mechanism known as
efferocytosis; the process known to engulf and remove apoptotic
cells. Failure in efferocytosis results in the disintegration of
apoptotic bodies and release of intracellular contents. This causes
inflammation that is known as secondary necrosis (Martin et al.,
2012). Importantly, apoptosis makes a crucial contribution to
the host immune response and determines the outcome of
infection. It abolishes the protected intracellular niche favoring
the replication of Mtb, thus forcing the bacteria to search for a
new habitat. The caspase family of serine proteases are the central
molecules responsible for the execution of apoptosis. Apoptosis
is classically induced by three pathways. First is through ligation
or oligomerization of tumor necrosis factor receptor (TNFR)
family. Ligation of cell surface receptor such as TNFR or Fas,
results in the subsequent activation of caspases and the induction
of apoptotic vesicles. Intrinsic apoptosis occurs in response to
oxidative stress, nutrient starvation or intracellular stress, which
changes the mitochondrial membrane permeability. It results
in the translocation of cytochrome c from mitochondria to
the cytoplasm, leading to the activation of caspases. The third
pathway is mediated by granzyme B released from cytolytic T cells
and NK cells.
Mycobacterium tuberculosis induces apoptosis through the
classical extrinsic pathway. Encounter of Mtb with innate cells
such as DCs and Mϕs induces the release of TNF-α and
triggers apoptosis. Apoptosis limits the replication of Mtb by
sequestering bacilli in apoptotic vesicles and by activating nearby
uninfected Mϕs. This phenomenon has been demonstrated
through a classical experiment in which uninfected autologous
Mϕs were cultured with apoptotic or necrotic or non-apoptotic
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infected Mϕs. Interestingly, significant inhibition in the growth
of Mtb was seen when apoptotic cells were cultured with
uninfected Mϕs. In coculture experiments, elimination of Mtb
was anticipated through efferocytosis. Later, antimicrobial effect
enacted by naïve Mϕs was shown to be contact independent
(Hartman and Kornfeld, 2011). Interleukin-1 signaling in naïve
Mϕs mediates the cross-talk with infected-Mϕs. It exhibits NO-
dependent antimicrobial activity against bacilli in autolysosomes
of heavily infected Mϕs (Hartman and Kornfeld, 2011).
Noteworthy, the discrepancy occurs in the induction of apoptosis
by avirulent versus virulent Mtb (Chen et al., 2006). Multiple
reports indicate that virulent Mtb induces necrosis to avoid host
defensive strategies, whereas attenuated strain is associated with
apoptosis (Chen et al., 2006; Divangahi et al., 2009). Despite
comparable amount of TNF-α, cells infected with avirulent
strain are more susceptible to apoptosis. It was revealed that
difference in level of apoptosis between Mtb strains is due to
an evasion strategy used by the virulent strain of Mtb. Cells
infected with virulent Mtb secrete more IL-10, which induces the
release of TNFR-2. Soluble TNFR-2 forms a complex with TNF-α
and downregulates the TNF-α induced apoptosis (Balcewicz-
Sablinska et al., 1998). Furthermore, it has been demonstrated
by Annexin V binding and intracellular caspase staining that
early secretory antigen target (ESAT)-6 of Mtb induces apoptosis
in human Mϕs (Choi et al., 2010). Additionally, the expression
profile of apoptotic genes shows up-regulation of anti-apoptotic
genes in virulent Mtb infected Mϕs.
In addition to the restriction of the Mtb growth during early
phase of infection, apoptosis has a considerable role in the
induction of the acquired cellular immune response (Winau et al.,
2006). The role of both CD4 T cells and CD8 T cells are well
documented in immunity against Mtb. However, the mechanism
underlying the presentation of antigens to CD8 T cells in context
with MHC-I molecules remains enigmatic. Recently, it has been
shown that apoptosis of infected Mϕs facilitates the release of
mycobacterial antigens in apoptotic vesicles, thereby allowing
their access to bystander APCs to present antigen to CD8 T
cells. Inhibition of apoptotic blebbing using caspase inhibitors,
hampers the CD8 T cell response (Winau et al., 2006). Therefore,
it may be concluded that triggering of apoptosis can efficiently
control the Mtb growth at early time points; and at later stages it
potentially contributes in the generation of antigen specific CD8
T cells.
Neutrophils are important cells of innate immunity. They play
a significant role in imparting protection to Mtb (Andersson
et al., 2014). These are the first cells to be recruited at the site
of infection. Neutrophils phagocytose Mtb. Furthermore, Mtb
infected neutrophils undergo apoptosis and are phagocytosed
by Mϕs. These Mϕs then release TNF-α to form granulomas
and control acute Mtb infection (Perskvist et al., 2002). Further,
inhibition of apoptosis in neutrophils delays the priming of CD4
T cells. Hence it implies that apoptosis plays a decisive role in
controlling Mtb infection by activating innate as well as adaptive
immunity. TLRs induced apoptosis such as TLR-3, 4 has been
explored for cancer therapy (Salaun et al., 2007). Interestingly,
TLRs show enough potential for triggering apoptosis in Mtb
infected cells. LpqH, a 19 and 38 kDa lipoprotein of Mtb induces
the Mϕ cell death in TLR-2 dependent manner (Ciaramella et al.,
2000; Sanchez et al., 2012). 38 kDa lipoprotein of Mtb elicits
the TNF-α release in TLR-2 dependent manner and induces
apoptosis in infected Mϕs (Sanchez et al., 2009). Apoptosis has
been shown to improve the efficacy of BCG vaccine. Deletion
of the secA2 gene of Mtb, which encodes a component of
a virulence-associated bacterial protein, triggers the apoptosis
of infected cells and enhances the priming of antigen specific
CD8 T cells. Vaccination with secA2 deleted Mtb mutant
induces better protection than BCG against Mtb (Boom, 2007;
Hinchey et al., 2007). rBCG strain that secretes listeriolysin of
Lysteria monocytogens induces more efficacious protection than
BCG against Mtb by facilitating the cross priming by inducing
apoptosis (Grode et al., 2005). This evidence indicates that
targeting apoptosis could be one of the potential strategies to
prevent TB.
Although apoptosis is the well-studied PCD, but it is not
the only mechanism responsible for this process. A new
form of non-apoptotic PCD has been termed as paraptosis.
Insulin like growth factor I receptor has been identified as a
molecule involved in inducing paroptosis. It is characterized by
cytoplasmic vacuolation, along with mitochondrial swelling, lack
of apoptotic morphology, caspase activation and inhibition by
caspase inhibitors (Sperandio et al., 2004). A few reports suggest
that this form of cell death is driven by an alternative caspase-
9 activity that is Apaf-1-independent (Sperandio et al., 2000).
Since, paraptosis follows the pathway different from apoptosis, it
could be a novel therapeutic target to kill pathogens that inhibits
apoptosis. Little is known about the effect of paraptosis on the
immune system and moieties involved in it. A few apoptotic
inducers have been shown to elicit paraptosis (Amarante-Mendes
et al., 1998). Nothing is known about its role in TB. In the future,
it may be an interesting line of investigation to understand the
contribution of paraptosis in limiting the Mtb growth.
Inflammasome
Mycobacterium tuberculosis activates the cascade of events
mediating the release of an array of pro-inflammatory cytokines
such as IL-6, IL-12, and TNF-α that play a defensive role in
eliciting innate immunity (Cooper et al., 2011). Similarly, IL-1β
and IL-18 have an influential role in imparting protection to Mtb.
IL-18 enhances the production of IFN-γ and its abrogation results
in less IFN-γ release and impaired NK cell function (Kawakami
et al., 2000). Simultaneously, IL-1R1-deficient mice show 2-log
increase in bacterial load in the lung and necrotic pneumonia
within 4 weeks of Mtb exposure. It is notable to mention that
cell mediated immunity (CMI), which is considered the hallmark
of protection against Mtb is not sufficient in restricting bacterial
burden in IL-1R deficient mice, despite efficient pulmonary CD4
T cell and CD8 T cell responses (Fremond et al., 2007).
Unlike other proinflammatory cytokines, IL-1β and IL-18 are
synthesized as precursors known as pro-IL-1β and pro-IL-18
(Sansonetti et al., 2000). Multiple signaling pathways triggered
through TLRs and cytokines result in the transcription of pro-IL-
1β and pro-IL-18. However, their maturation requires processing
by active caspases. Distinct caspases regulate the apoptosis
and maturation of IL-1β and IL-18. Caspase-1 regulates the
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maturation of IL-1β and IL-18 (Dinarello, 2006). Importantly,
release of IL-1β and IL-18 is highly regulated phenomenon, which
is dependent on the activation of caspase-1 and its homolog
by multimeric protein complex termed as inflammasomes
(Vladimer et al., 2013). These complexes are critical in the
proteolytic processing of pro-IL-1β and pro-IL-18 into their
active form (Netea et al., 2010; Briken et al., 2013). The
inflammasome is classically composed of NOD like receptors
(NLRs), the adaptor molecule PYCARD/ASC, and pro-caspase-
1, which when proteolyzed to caspase-1 provides the enzymatic
activity of the inflammasome. Pro-caspase-1 forms the core of
the inflammasome. However, the constitution of NLRs within
the inflammasome varies according to the type of pathogen
involved. The NLR family members NALP3, NAIP5, or IPAF and
the adaptor apoptosis speck-like protein (ASC) are involved in
caspase-1 activation. Inflammasome plays an important role in
host defense against Mtb, since mice deficient in IL-1 receptor
(IL-1RI), IL-1β or IL-18 are more susceptible to infection with
Mtb. Furthermore, a defect in ASC adaptor protein shows the
exacerbation of disease without restricting the Mtb growth.
Early secreted antigenic target protein 6 kilodalton secretion
system (ESX)-1 encoded in RD-1 region of Mtb promotes the
release of IL-1β by inflammasome activation. ESX-1 mediated
inflammasome formation depends on host NLRP-3 and ASC
protein (Mishra et al., 2010). RD-1 deficient Mtb fails to induce a
strong activation of caspase-1 resulting in inefficient secretion of
IL-1β and IL-18. This observation signifies that the failure of BCG
to mount optimal protection against Mtb is due to absence of
RD-1 dependent induction of IL-1β and IL-18 (Kurenuma et al.,
2009). Interestingly, treatment with exogenous IL-18 reduces
the bacterial load in mice. Recently, viral and bacterial RNA
have been shown to trigger NLRP3 and activate inflammasome
(Mitoma et al., 2013). It suggests that prophylactic strategies
employing recombinant BCG expressing innate ligands, which
are efficient in inducing inflammasome formation, can boost
its protective efficacy against TB. Mtb genes Rv0198c (zmp1),
plays a critical role in preventing caspase-1-dependent activation
and secretion of IL-1β. zmp1-deleted Mtb triggered activation
of the inflammasome, resulting in increased release of IL-1β,
enhanced maturation of Mtb containing phagosomes, improved
mycobacterial clearance by macrophages, and reduction in
bacterial load in the lungs of Mtb aerosol-infected mice (Master
et al., 2008). Zmp1 is an important virulence determinant and
represents a potentially useful drug target. Furthermore, it has
been shown that binding of vitamin D induces IL-1β secretion
and prevent infection. This information supports the idea of
exploiting vitamin D in clinical trials against Mtb (Verway et al.,
2013).
Inflammasomes are also reported to play an important
part in amplifying the adaptive immune response. Importantly,
inflammasome processed IL-1β promotes the differentiation of
naïve CD4 T cells to Th17 subtype. It synergizes with IL-
6 and promotes Th17 cell development via up-regulation of
key cytokine IL-17, transcription factors, IRF4 and RORγt.
Furthermore, IL-1β can coordinate with IL-6 and IL-23 in the
absence of TGF-β signaling to induce pathogenic Th17 cells
(Ghoreschi et al., 2010). In addition to Th1 cells, Th17 cells
also play a cardinal role in generating anti-Mtb response. IL-
17 induces the expression of chemokines that results in the
recruitment of various cells to the site of infection. Furthermore,
memory Th17 cells promote rapid migration of Th1 cells by
enhancing the expression of chemokines (Khader and Cooper,
2008). Toll-like receptors and NOD-2 expressed on APCs are
responsible for the induction and release of cytokines like IL-6,
TGF-β, and IL-12 that are responsible for the differentiation of
Th17 cells and Th1 cells, respectively (Khan et al., 2016). Hence
immunotherapies involving agonists of innate immunity can be
explored in the generation of protective immunity against Mtb
(Chodisetti et al., 2015). The above showcased points indicate that
innate immunity efficiently controls the Mtb growth during early
phase of infection. Moreover, it creates a platform for adaptive
immunity.
CONCLUSION
Continuous efforts are undertaken to generate an effective
vaccine against TB. However, a possible candidate that can
achieve the WHO-STOP-TB program has not yet been
formulated. Eleven candidate vaccines are currently in clinical
trials. Failure of BCG to protect against Mtb warrants a serious
attempt to reinvigorate BCG potency for inducing optimal
immune response (Singh et al., 2010; Gowthaman et al., 2011,
2012).
Recently, innate immunity has emerged as a cornerstone in
limiting the growth of Mtb (Fremond et al., 2004; Nicolle et al.,
2004; Carlos et al., 2009). Innate immunity not only initiates
series of events to assist adaptive immunity but also restricts the
growth of TB bacilli at the initial phase of infection. Nonetheless,
failure of innate killing mechanisms results in unobstructed
growth of Mtb and provides enough opportunity for the pathogen
to breach the barrier of the immune system. It indicates that
targeting innate immunity is a judicious approach to consider,
while designing vaccines or therapeutics. Inefficiency of innate
immunity provides an opportunity for unimpeded Mtb growth.
Later, the Mtb conquers the adaptive immunity. Adequate innate
immunity is capable of restricting the growth of Mtb during
the “lag phase” of T cell response. Limiting the growth of Mtb
during the initial phase of infection provides enough time for
T cells to reach the site of infection and curtail Mtb replication.
However, impaired innate immunity is incompetent in curbing
the proliferation of Mtb. It results in unhindered growth of
Mtb, which ultimately interferes in the activation of adaptive
immunity. Biological therapies involving innate ligands for TLRs
and NLRs will benefit the quest for novel treatment modalities
for TB. We speculate that mycobacterial vaccines engineered
with ligands for PRRs may enhance the potency of innate
immunity to limit the Mtb growth and sustain the adaptive arm
of immunity.
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